Ken Griffin Rani Therapeutics Holdings, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,500 shares of RANI stock, worth $3,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,000
25.0%
Holding current value
$3,650
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.76 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.04 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$720,6321.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$654,7980.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$442,0040.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $35.8M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...